MelliCell is developing an oral pill for obesity, autism, and dementia by targeting a shared genetic switch at the root of all three diseases
MelliCell is developing an oral pill for obesity, autism, and dementia by targeting a shared genetic switch at the root of all three diseases. The company uses a proprietary discovery engine to create a novel, once-daily oral therapy that has shown safety in animal trials and aims to enter clinical trials for proof of concept.